BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6245710)

  • 1. The effect of diamide on cyclic AMP levels and cyclic nucleotide phosphodiesterase in human peripheral blood lymphocytes.
    Wedner HJ
    Biochim Biophys Acta; 1980 Apr; 628(4):407-18. PubMed ID: 6245710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of cyclic nucleotide phosphodiesterase from isolated human peripheral blood lymphocytes by mitogenic agents.
    Epstein PM; Mills JS; Hersh EM; Strada SJ; Thompson WJ
    Cancer Res; 1980 Feb; 40(2):379-86. PubMed ID: 6243252
    [No Abstract]   [Full Text] [Related]  

  • 3. Do conventional plasma cyclic nucleotide phosphodiesterase inhibitors really work in all situations?
    Wood PJ; Pao G; Ross G; Smith C
    Clin Chim Acta; 1981 Sep; 115(3):405-8. PubMed ID: 6271425
    [No Abstract]   [Full Text] [Related]  

  • 4. Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from the cytosol of human platelets.
    Grant PG; Mannarino AF; Colman RW
    Thromb Res; 1990 Jul; 59(1):105-19. PubMed ID: 2169075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High activity of cyclic 3',5'-nucleotide phosphodiesterase in sera of patient with phaeochromocytoma.
    Nakai A; Nagasaka A; Ohyama T; Aono T; Iwase K; Hasegawa H; Hayami S; Hidaka H; Tanaka T; Niinomi M
    Clin Endocrinol (Oxf); 1986 Apr; 24(4):409-14. PubMed ID: 3017609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on plasma cyclic nucleotide, cyclic nucleotide phosphodiesterase, beta-thromboglobulin, and myoglobin response in patients with acute myocardial infarction.
    Kurokawa Y; Fukuda I; Mozai T
    Bull Osaka Med Sch; 1983 Oct; 29(2):85-97. PubMed ID: 6210124
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic nucleotide phosphodiesterase inhibition by a benzoic acid derivative.
    Killackey JJ; Killackey BA; Philp RB
    Agents Actions; 1985 Dec; 17(2):192-6. PubMed ID: 2420162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.
    Hidaka H; Hayashi H; Kohri H; Kimura Y; Hosokawa T; Igawa T; Saitoh Y
    J Pharmacol Exp Ther; 1979 Oct; 211(1):26-30. PubMed ID: 226672
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclic nucleotide phosphodiesterase activity and the platelet release reaction.
    Taylor PM; Heptinstall S
    Thromb Haemost; 1978 Apr; 39(2):550-1. PubMed ID: 27878
    [No Abstract]   [Full Text] [Related]  

  • 11. Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase.
    Grant PG; Colman RW
    Biochemistry; 1984 Apr; 23(8):1801-7. PubMed ID: 6326810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cyclic 3',5'-nucleotide phosphodiesterase in patients with various thyroid disorders.
    Nagasaka A; Hasegawa H; Hayami S; Hidaka H; Tanaka T; Niinomi M; Nihei N; Nakagawa H; Ohyama T; Aono T
    Enzyme; 1985; 33(1):18-24. PubMed ID: 2985379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early increase in lymphocyte cyclic nucleotide phosphodiesterase activity upon mitogenic activation of human peripheral blood mononuclear cells.
    Meskini N; Hosni M; Nemoz G; Lagarde M; Prigent AF
    J Cell Physiol; 1992 Jan; 150(1):140-8. PubMed ID: 1309823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition by NPT 15392 of lymphocyte cyclic GMP phosphodiesterase.
    Coffey RG; Hartley L; Polson JB; Krzanowski JJ; Hadden JW
    Biochem Pharmacol; 1984 Nov; 33(21):3411-7. PubMed ID: 6093811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
    Souness JE; Diocee BK; Martin W; Moodie SA
    Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolism of cyclic nucleotides in the guinea-pig pancreas. Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase.
    Methven P; Lemon M; Bhoola K
    Biochem J; 1980 Feb; 186(2):491-8. PubMed ID: 6246887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP and cyclic GMP phosphodiesterase activities in Hodgkin's disease lymphocytes.
    Aleksijevic A; Lugnier C; Giron C; Mayer S; Stoclet JC; Lang JM
    Int J Immunopharmacol; 1987; 9(5):525-31. PubMed ID: 3040609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3':5'-cyclic-nucleotide phosphodiesterases of mammalian sera.
    Asano T; Hidaka H
    Biochim Biophys Acta; 1975 Jul; 397(1):124-33. PubMed ID: 238629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction.
    Ahluwalia GS; Rhoads AR
    Biochem Pharmacol; 1982 Mar; 31(5):665-9. PubMed ID: 6177320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic nucleotide phosphodiesterases from purified human CD4+ and CD8+ T lymphocytes.
    Tenor H; Staniciu L; Schudt C; Hatzelmann A; Wendel A; Djukanović R; Church MK; Shute JK
    Clin Exp Allergy; 1995 Jul; 25(7):616-24. PubMed ID: 8521180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.